XRN · Chiron Real Estate Inc.

Track XRN — free

$33.81 -0.20 (-0.59%) At close · Oct 5

Russell 2000 member Rebalance outlook locked

Market Cap

$473.25M

13.24M

Volume · Oct 5 127.62K Avg daily vol (3M) 90.09K

Up next

Next earnings call

Nov 5, 2026 Est · unconfirmed · in 4 wks

Latest filing: 10-Q

filed Aug 10, 2026

Q1 2026 earnings call transcript

call held May 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

—

Trailing 12 months

Net income (TTM)

—

Trailing 12 months

Revenue growth YoY

—

Year over year

Operating margin

—

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

—

Year over year · more shares

Price change (1Y)

+3.7%

Trailing year

Short interest

7.1%

Latest settlement · 8.9 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Low

Market backdrop VIX 15.5 · calm Equity put/call 0.59

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −5%

below

Price vs 50-day avg −7%

below

RSI (14) 29

oversold

MACD trend Negative

52-week position 46%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −9%

trailing

6-month return −5%

trailing

YTD return 0%

this year

Relative strength −16%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $36 › 200d $36 — 50d above 200d

Institutional flow Distributing

4 of 170 funds reported for Sep 30 · net -4.9K sh shares

Insider flow Accumulating

Net +$2.6M over 90 days · 0% sells

Short interest Rising

7.13% of float · ▲ +9.8% MoM · 8.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

170 holders — near 1-yr high, broad support

Squeeze score 69

elevated · 0–100

Fundamentals

Strong

Revenue growth +7%

Y/Y

EPS growth −1617%

Y/Y

Free cash flow $41.8M

Buyback $44.0M

remaining

Balance sheet $7.9M

net cash

Quant / Vol

risk profile

Low

Volatility 28%

annualized · 1-yr

Max drawdown −13%

past year

ATR 2.3%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Prior guidance period ended · from the 8-K filed Nov 4, 2025

AFFO per share and unit · full year 2025 $4.50 – $4.60

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 4 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−5% Bearish

Price vs 50-day avg

−7% Bearish

RSI (14)

29 Neutral

MACD trend

Negative Bearish

52-week position

46% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $36 › 200d $36 — 50d above 200d

Institutional flow Distributing

4 of 170 funds reported for Sep 30 · net -4.9K sh shares

Insider flow Accumulating

Net +$2.6M over 90 days · 0% sells

Short interest Rising

7.13% of float · ▲ +9.8% MoM · 8.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

170 holders — near 1-yr high, broad support

Price context

position in its 52-week range

Range low $30 Now $34 · 46% Range high $38

vs 200-day avg -5% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDAre non-GAAP	$26.12M	Three Months Ended June 30, 2026 filing	—
Cash NOI non-GAAP	$30.09M	Three Months Ended June 30, 2026 filing	—
Core FFO attributable to common stockholders and noncontrolling interest non-GAAP	15.1M	Three Months Ended June 30, 2026 filing	—
Core FFO attributable to common stockholders and noncontrolling interest per share and unit non-GAAP	$1.04	Three Months Ended June 30, 2026 filing	—
EBITDAre non-GAAP	24.59M	Three Months Ended June 30, 2026 filing	—
FAD attributable to common stockholders and noncontrolling interest non-GAAP	11.7M	Three Months Ended June 30, 2026 filing	—
FFO attributable to common stockholders and noncontrolling interest non-GAAP	12.74M	Three Months Ended June 30, 2026 filing	—
FFO attributable to common stockholders and noncontrolling interest per share and unit non-GAAP	$0.88	Three Months Ended June 30, 2026 filing	—
NOI non-GAAP	$29.82M	Three Months Ended June 30, 2026 filing	—
Same-Property Cash NOI non-GAAP	$24.11M	Three Months Ended June 30, 2026 filing	—
SHOP Segment NOI	$0.3M	the three months ended June 30, 2026 filing	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
XRN Chiron Real Estate Inc. this stock	$473.25M	+0.2%	+6.8%	—	7.1%
WELL Welltower Inc.	$163.33B	+20.8%	+35.6%	115.1	2.5%
VTR Ventas, Inc.	$44.42B	+5.1%	+18.5%	160.4	3.9%
OHI Omega Healthcare Investors Inc	$14.02B	+2.3%	+13.2%	16.5	4.8%
DOC Healthpeak Properties, Inc.	$13.61B	+17.2%	+4.5%	56.4	3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

170

% held: 75.5%
Reported: 4 of 170
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

141

View

Short & Settlement

Short Interest Rising

Shares short

944.0K

Days to cover: 8.9d
Change: +84.0K sh

View

Short Volume

Short vol %

50%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $2.2K
As of: Sep 8, 2026

View

Off-Exchange

Off-exchange %

36.7%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Cluster buy

Net (90d)

+$2.6M

Buyers / Sellers: 4 / 0

Buyers Sellers

View

Congressional Trades Sell

Member

Thomas R Carper

Amount: $1.0K–$15.0K
Traded: Oct 17, 2022

View

Financials

Revenue (FY)

$148.2M

Net income (FY): $-6.9M
EPS diluted: $-0.91

View

Buybacks

Authorized

$50.0M

Remaining: $44.0M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Oct 5, 2026
This year: 19

View

Proposed Sales

Value

$878.0K

Shares: 130.0K
Filed: Aug 15, 2025

View

Exempt Offerings

Offering

$100.0M

Filed: Jun 15, 2026

View

Earnings & Events

Webcasts

Last webcast

Aug 6, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
XRN	-4.6%	-8.5%	-4.6%	-2.7%	+0.2%
SPY	+1.2%	+0.6%	+11.6%	+1.6%	+13.6%
vs SPY	-5.8%	-9.1%	-16.1%	-4.3%	-13.4%

Capital returns

Buyback program · as of Jun 30, 2026

Authorized

$50.00M

Spent (derived)

$6.00M

Remaining

$44.00M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1533615 CUSIP 37954A303 13F (30d) 7 filings 7 filers Visit website Investor relations

XRN · Chiron Real Estate Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns